GlaxoSmithKline Income Statement
View: Annual
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 45,816.1 | 45,479.2 | 37,272.5 |
| Cost of Goods Sold | 10,619.6 | -- | 8,197.9 |
| Gross Profit | 35,196.4 | -- | 29,074.6 |
| Gross Profit Margin | 76.8% | 0.0% | 78.0% |
| SG&A Expense | 18,073.6 | -- | 18,448.7 |
| Depreciation & Amortization | 2,041.2 | -- | 1,555.6 |
| Operating Income | 15,081.6 | -- | 9,070.3 |
| Operating Margin | 32.9% | -- | 24.3% |
| Nonoperating Income | 569.2 | -- | (86.0) |
| Nonoperating Expenses | 866.8 | -- | 734.8 |
| Income Before Taxes | 14,883.9 | -- | 8,031.0 |
| Income Taxes | 4,278.2 | -- | 2,290.4 |
| Net Income After Taxes | 10,605.7 | 0.0 | 5,740.6 |
| Continuing Operations | 10,605.7 | -- | 5,740.6 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 10,605.7 | -- | 5,740.6 |
| Total Net Income | 10,605.7 | -- | 5,740.6 |
| Net Profit Margin | 23.1% | -- | 15.4% |
| Diluted EPS from Total Net Income ($) | 1.87 | -- | 2.12 |
| Dividends per Share | 2.06 | -- | 1.53 |
This data is provided as per license from EDGAR Online
